SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5vsd'

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)	View	Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1PNL_B_PACB559_0 (PENICILLIN AMIDOHYDROLASE)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	4 / 8	SER A1196 PHE A1226 ILE A1187 ASN A1194	None	0.85A	1pnlA-5vsdA: undetectable 1pnlB-5vsdA: undetectable	1pnlA-5vsdA: 19.07 1pnlB-5vsdA: 16.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2AJV_L_COCL501_1 (ANTIBODY 7A1 FAB')	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	4 / 7	ALA A1189 TYR A1173 ARG A1190 PHE A1198	None SAM  A3001 (-4.0A) None None	1.18A	2ajvH-5vsdA: undetectable 2ajvL-5vsdA: undetectable	2ajvH-5vsdA: 15.33 2ajvL-5vsdA: 22.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2H21_A_SAMA801_0 (RIBULOSE-1,5 BISPHOSPHATE CARBOXYLASE/OXYGENAS E)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	5 / 10	GLY A1137 SER A1172 ASN A1200 HIS A1201 TYR A1242	SAM  A3001 (-3.6A) SAM  A3001 (-3.7A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A)	0.52A	2h21A-5vsdA: 7.2	2h21A-5vsdA: 19.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2H21_B_SAMB802_0 (RIBULOSE-1,5 BISPHOSPHATE CARBOXYLASE/OXYGENAS E)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	5 / 11	GLY A1137 SER A1172 ASN A1200 HIS A1201 TYR A1242	SAM  A3001 (-3.6A) SAM  A3001 (-3.7A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A)	0.59A	2h21B-5vsdA: 7.0	2h21B-5vsdA: 19.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2H21_C_SAMC803_0 (RIBULOSE-1,5 BISPHOSPHATE CARBOXYLASE/OXYGENAS E)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	5 / 11	GLY A1137 SER A1172 ASN A1200 HIS A1201 TYR A1242	SAM  A3001 (-3.6A) SAM  A3001 (-3.7A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A)	0.55A	2h21C-5vsdA: 6.7	2h21C-5vsdA: 19.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QE6_B_SAMB400_1 (UNCHARACTERIZED PROTEIN TFU_2867)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	3 / 3	ASN A1122 ARG A1125 ASP A1085	None	0.97A	2qe6B-5vsdA: undetectable	2qe6B-5vsdA: 19.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2R3A_A_SAMA304_0 (HISTONE-LYSINE N-METHYLTRANSFERASE SUV39H2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	7 / 12	GLY A1137 TRP A1138 TYR A1173 HIS A1201 TYR A1242 CYH A1256 CYH A1258	SAM  A3001 (-3.6A) None SAM  A3001 (-4.0A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 ( 2.4A) ZN  A3005 (-2.3A)	0.41A	2r3aA-5vsdA: 28.2	2r3aA-5vsdA: 35.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W3B_B_FOLB401_0 (DIHYDROFOLATE REDUCTASE)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	5 / 12	ILE A1146 ALA A1234 ILE A1021 PRO A1022 LEU A1124	None	1.17A	2w3bB-5vsdA: undetectable	2w3bB-5vsdA: 20.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2WB9_A_CYSA301_0 (GLUTATHIONE TRANSFERASE SIGMA CLASS)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	4 / 5	GLY A1193 ARG A1197 TYR A1038 TYR A1040	None	1.46A	2wb9A-5vsdA: undetectable	2wb9A-5vsdA: 20.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OOI_A_SAMA237_0 (HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-36 AND H4 LYSINE-20 SPECIFIC)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	8 / 12	GLY A1137 TRP A1138 TYR A1173 ASN A1200 HIS A1201 TYR A1242 CYH A1256 CYH A1258	SAM  A3001 (-3.6A) None SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 ( 2.4A) ZN  A3005 (-2.3A)	0.43A	3ooiA-5vsdA: 19.6	3ooiA-5vsdA: 30.39
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OOI_A_SAMA237_0 (HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-36 AND H4 LYSINE-20 SPECIFIC)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	6 / 12	GLY A1137 TRP A1138 TYR A1173 HIS A1201 TYR A1242 CYH A1258	SAM  A3001 (-3.6A) None SAM  A3001 (-4.0A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.42A	3ooiA-5vsdA: 19.6	3ooiA-5vsdA: 30.39
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OOI_A_SAMA237_0 (HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-36 AND H4 LYSINE-20 SPECIFIC)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	5 / 12	GLY A1139 TYR A1173 HIS A1201 TYR A1242 CYH A1258	None SAM  A3001 (-4.0A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.42A	3ooiA-5vsdA: 19.6	3ooiA-5vsdA: 30.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OPE_A_SAMA7_0 (PROBABLE HISTONE-LYSINE N-METHYLTRANSFERASE ASH1L)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	5 / 12	GLY A1137 TRP A1138 HIS A1201 TYR A1242 CYH A1258	SAM  A3001 (-3.6A) None SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.30A	3opeA-5vsdA: 18.1	3opeA-5vsdA: 29.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OPE_A_SAMA7_0 (PROBABLE HISTONE-LYSINE N-METHYLTRANSFERASE ASH1L)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	7 / 12	GLY A1137 TRP A1138 TYR A1173 ASN A1200 HIS A1201 TYR A1242 CYH A1256	SAM  A3001 (-3.6A) None SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 ( 2.4A)	0.47A	3opeA-5vsdA: 18.1	3opeA-5vsdA: 29.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OPE_B_SAMB8_0 (PROBABLE HISTONE-LYSINE N-METHYLTRANSFERASE ASH1L)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	5 / 9	GLY A1137 TRP A1138 TYR A1173 ASN A1200 TYR A1242	SAM  A3001 (-3.6A) None SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.8A)	0.46A	3opeB-5vsdA: 17.5	3opeB-5vsdA: 29.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3QXY_A_SAMA6734_0 (N-LYSINE METHYLTRANSFERASE SETD6)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	5 / 12	GLY A1137 TYR A1173 ASN A1200 HIS A1201 TYR A1242	SAM  A3001 (-3.6A) SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A)	0.65A	3qxyA-5vsdA: 7.3	3qxyA-5vsdA: 17.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RC0_B_SAMB480_0 (N-LYSINE METHYLTRANSFERASE SETD6)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	5 / 12	GLY A1137 TYR A1173 ASN A1200 HIS A1201 TYR A1242	SAM  A3001 (-3.6A) SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A)	0.62A	3rc0B-5vsdA: 7.2	3rc0B-5vsdA: 17.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3S8P_A_SAMA500_0 (HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	5 / 12	ASN A1200 HIS A1201 TYR A1242 CYH A1256 CYH A1258	SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 ( 2.4A) ZN  A3005 (-2.3A)	0.39A	3s8pA-5vsdA: 10.7	3s8pA-5vsdA: 21.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ZOA_A_ACRA1587_2 (TREHALOSE SYNTHASE/AMYLASE TRES)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	3 / 3	ARG A1220 PHE A1221 PRO A1222	None	0.82A	3zoaB-5vsdA: undetectable	3zoaB-5vsdA: 18.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4BUP_A_SAMA500_0 (HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	5 / 12	ASN A1200 HIS A1201 TYR A1242 CYH A1256 CYH A1258	SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 ( 2.4A) ZN  A3005 (-2.3A)	0.40A	4bupA-5vsdA: 10.6	4bupA-5vsdA: 21.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YNM_A_SAMA2304_0 (HISTONE-LYSINE N-METHYLTRANSFERASE ASH1L)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	6 / 12	GLY A1137 TRP A1138 ASN A1200 HIS A1201 TYR A1242 CYH A1256	SAM  A3001 (-3.6A) None SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 ( 2.4A)	0.51A	4ynmA-5vsdA: 18.2	4ynmA-5vsdA: 29.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YNM_A_SAMA2304_0 (HISTONE-LYSINE N-METHYLTRANSFERASE ASH1L)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	5 / 12	GLY A1137 TRP A1138 HIS A1201 TYR A1242 CYH A1258	SAM  A3001 (-3.6A) None SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.24A	4ynmA-5vsdA: 18.2	4ynmA-5vsdA: 29.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YNM_B_SAMB2304_0 (HISTONE-LYSINE N-METHYLTRANSFERASE ASH1L)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	7 / 12	GLY A1137 TRP A1138 TYR A1173 ASN A1200 HIS A1201 TYR A1242 CYH A1256	SAM  A3001 (-3.6A) None SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 ( 2.4A)	0.39A	4ynmB-5vsdA: 18.2	4ynmB-5vsdA: 29.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YNM_B_SAMB2304_0 (HISTONE-LYSINE N-METHYLTRANSFERASE ASH1L)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	6 / 12	GLY A1137 TRP A1138 TYR A1173 HIS A1201 TYR A1242 CYH A1258	SAM  A3001 (-3.6A) None SAM  A3001 (-4.0A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.38A	4ynmB-5vsdA: 18.2	4ynmB-5vsdA: 29.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YNM_B_SAMB2304_0 (HISTONE-LYSINE N-METHYLTRANSFERASE ASH1L)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	5 / 12	GLY A1139 TYR A1173 HIS A1201 TYR A1242 CYH A1258	None SAM  A3001 (-4.0A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.11A	4ynmB-5vsdA: 18.2	4ynmB-5vsdA: 29.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YNP_A_SAMA2304_0 (HISTONE-LYSINE N-METHYLTRANSFERASE ASH1L)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	7 / 12	GLY A1137 TRP A1138 TYR A1173 HIS A1201 TYR A1242 CYH A1256 CYH A1258	SAM  A3001 (-3.6A) None SAM  A3001 (-4.0A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 ( 2.4A) ZN  A3005 (-2.3A)	0.55A	4ynpA-5vsdA: 18.1	4ynpA-5vsdA: 29.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YNP_A_SAMA2304_0 (HISTONE-LYSINE N-METHYLTRANSFERASE ASH1L)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	6 / 12	GLY A1137 TRP A1138 TYR A1173 HIS A1201 TYR A1242 CYH A1258	SAM  A3001 (-3.6A) None SAM  A3001 (-4.0A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.35A	4ynpA-5vsdA: 18.1	4ynpA-5vsdA: 29.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YNP_A_SAMA2304_0 (HISTONE-LYSINE N-METHYLTRANSFERASE ASH1L)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	5 / 12	GLY A1139 TYR A1173 HIS A1201 TYR A1242 CYH A1258	None SAM  A3001 (-4.0A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.03A	4ynpA-5vsdA: 18.1	4ynpA-5vsdA: 29.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YNP_A_SAMA2304_0 (HISTONE-LYSINE N-METHYLTRANSFERASE ASH1L)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	5 / 12	GLY A1139 TYR A1173 HIS A1201 TYR A1242 CYH A1258	None SAM  A3001 (-4.0A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.43A	4ynpA-5vsdA: 18.1	4ynpA-5vsdA: 29.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YNP_B_SAMB2304_0 (HISTONE-LYSINE N-METHYLTRANSFERASE ASH1L)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	7 / 10	GLY A1137 TRP A1138 TYR A1173 ASN A1200 HIS A1201 TYR A1242 CYH A1256	SAM  A3001 (-3.6A) None SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 ( 2.4A)	0.42A	4ynpB-5vsdA: 18.0	4ynpB-5vsdA: 29.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YNP_B_SAMB2304_0 (HISTONE-LYSINE N-METHYLTRANSFERASE ASH1L)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	7 / 10	GLY A1137 TRP A1138 TYR A1173 ASN A1200 HIS A1201 TYR A1242 CYH A1258	SAM  A3001 (-3.6A) None SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.34A	4ynpB-5vsdA: 18.0	4ynpB-5vsdA: 29.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YNP_B_SAMB2304_0 (HISTONE-LYSINE N-METHYLTRANSFERASE ASH1L)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	5 / 10	GLY A1139 TYR A1173 HIS A1201 TYR A1242 CYH A1256	None SAM  A3001 (-4.0A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 ( 2.4A)	1.49A	4ynpB-5vsdA: 18.0	4ynpB-5vsdA: 29.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YNP_B_SAMB2304_0 (HISTONE-LYSINE N-METHYLTRANSFERASE ASH1L)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	5 / 10	GLY A1139 TYR A1173 HIS A1201 TYR A1242 CYH A1258	None SAM  A3001 (-4.0A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.17A	4ynpB-5vsdA: 18.0	4ynpB-5vsdA: 29.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YPA_A_SAMA3004_0 (HISTONE-LYSINE N-METHYLTRANSFERASE ASH1L)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	7 / 12	GLY A1137 TRP A1138 TYR A1173 ASN A1200 HIS A1201 TYR A1242 CYH A1256	SAM  A3001 (-3.6A) None SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 ( 2.4A)	0.47A	4ypaA-5vsdA: 18.7	4ypaA-5vsdA: 29.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YPA_A_SAMA3004_0 (HISTONE-LYSINE N-METHYLTRANSFERASE ASH1L)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	6 / 12	GLY A1137 TRP A1138 TYR A1173 HIS A1201 TYR A1242 CYH A1258	SAM  A3001 (-3.6A) None SAM  A3001 (-4.0A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.33A	4ypaA-5vsdA: 18.7	4ypaA-5vsdA: 29.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YPA_B_SAMB2304_0 (HISTONE-LYSINE N-METHYLTRANSFERASE ASH1L)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	6 / 12	GLY A1137 TRP A1138 ASN A1200 HIS A1201 TYR A1242 CYH A1256	SAM  A3001 (-3.6A) None SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 ( 2.4A)	0.31A	4ypaB-5vsdA: 18.4	4ypaB-5vsdA: 29.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YPA_B_SAMB2304_0 (HISTONE-LYSINE N-METHYLTRANSFERASE ASH1L)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	5 / 12	GLY A1137 TRP A1138 HIS A1201 TYR A1242 CYH A1258	SAM  A3001 (-3.6A) None SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.17A	4ypaB-5vsdA: 18.4	4ypaB-5vsdA: 29.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YPA_C_SAMC2304_0 (HISTONE-LYSINE N-METHYLTRANSFERASE ASH1L)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	6 / 12	GLY A1137 TRP A1138 ASN A1200 HIS A1201 TYR A1242 CYH A1256	SAM  A3001 (-3.6A) None SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 ( 2.4A)	0.46A	4ypaC-5vsdA: 18.9	4ypaC-5vsdA: 29.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YPA_C_SAMC2304_0 (HISTONE-LYSINE N-METHYLTRANSFERASE ASH1L)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	5 / 12	GLY A1137 TRP A1138 HIS A1201 TYR A1242 CYH A1258	SAM  A3001 (-3.6A) None SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.20A	4ypaC-5vsdA: 18.9	4ypaC-5vsdA: 29.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YPA_D_SAMD2304_0 (HISTONE-LYSINE N-METHYLTRANSFERASE ASH1L)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	7 / 12	GLY A1137 TRP A1138 TYR A1173 ASN A1200 HIS A1201 TYR A1242 CYH A1256	SAM  A3001 (-3.6A) None SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 ( 2.4A)	0.38A	4ypaD-5vsdA: 18.5	4ypaD-5vsdA: 29.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YPA_D_SAMD2304_0 (HISTONE-LYSINE N-METHYLTRANSFERASE ASH1L)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	6 / 12	GLY A1137 TRP A1138 TYR A1173 HIS A1201 TYR A1242 CYH A1258	SAM  A3001 (-3.6A) None SAM  A3001 (-4.0A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.29A	4ypaD-5vsdA: 18.5	4ypaD-5vsdA: 29.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YPE_A_SAMA2304_0 (HISTONE-LYSINE N-METHYLTRANSFERASE ASH1L)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	5 / 12	GLY A1137 TRP A1138 HIS A1201 TYR A1242 CYH A1258	SAM  A3001 (-3.6A) None SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.26A	4ypeA-5vsdA: 18.9	4ypeA-5vsdA: 29.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YPE_A_SAMA2304_0 (HISTONE-LYSINE N-METHYLTRANSFERASE ASH1L)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	7 / 12	GLY A1137 TRP A1138 TYR A1173 ASN A1200 HIS A1201 TYR A1242 CYH A1256	SAM  A3001 (-3.6A) None SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 ( 2.4A)	0.49A	4ypeA-5vsdA: 18.9	4ypeA-5vsdA: 29.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YPE_B_SAMB2304_0 (HISTONE-LYSINE N-METHYLTRANSFERASE ASH1L)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	5 / 11	GLY A1137 TRP A1138 HIS A1201 TYR A1242 CYH A1258	SAM  A3001 (-3.6A) None SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.29A	4ypeB-5vsdA: 18.6	4ypeB-5vsdA: 29.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YPE_B_SAMB2304_0 (HISTONE-LYSINE N-METHYLTRANSFERASE ASH1L)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	7 / 11	GLY A1137 TRP A1138 TYR A1173 ASN A1200 HIS A1201 TYR A1242 CYH A1256	SAM  A3001 (-3.6A) None SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 ( 2.4A)	0.25A	4ypeB-5vsdA: 18.6	4ypeB-5vsdA: 29.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YPU_A_SAMA2304_0 (HISTONE-LYSINE N-METHYLTRANSFERASE ASH1L)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	7 / 12	GLY A1137 TRP A1138 TYR A1173 ASN A1200 HIS A1201 TYR A1242 CYH A1256	SAM  A3001 (-3.6A) None SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 ( 2.4A)	0.45A	4ypuA-5vsdA: 18.3	4ypuA-5vsdA: 28.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YPU_A_SAMA2304_0 (HISTONE-LYSINE N-METHYLTRANSFERASE ASH1L)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	6 / 12	GLY A1137 TRP A1138 TYR A1173 HIS A1201 TYR A1242 CYH A1258	SAM  A3001 (-3.6A) None SAM  A3001 (-4.0A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.38A	4ypuA-5vsdA: 18.3	4ypuA-5vsdA: 28.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YPU_A_SAMA2304_0 (HISTONE-LYSINE N-METHYLTRANSFERASE ASH1L)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	5 / 12	GLY A1139 TYR A1173 HIS A1201 TYR A1242 CYH A1258	None SAM  A3001 (-4.0A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.10A	4ypuA-5vsdA: 18.3	4ypuA-5vsdA: 28.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YPU_B_SAMB2304_0 (HISTONE-LYSINE N-METHYLTRANSFERASE ASH1L)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	6 / 11	GLY A1137 TRP A1138 TYR A1173 ASN A1200 HIS A1201 TYR A1242	SAM  A3001 (-3.6A) None SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A)	0.52A	4ypuB-5vsdA: 17.8	4ypuB-5vsdA: 28.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5CPR_B_SAMB402_0 (HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	5 / 12	PHE A1198 HIS A1201 TYR A1242 CYH A1256 CYH A1258	None SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 ( 2.4A) ZN  A3005 (-2.3A)	1.36A	5cprB-5vsdA: 9.5	5cprB-5vsdA: 21.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5JHN_A_SAMA1205_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	12 / 12	MET A1136 GLY A1137 TRP A1138 SER A1172 TYR A1173 ASN A1200 HIS A1201 TYR A1242 PHE A1246 LYS A1250 PHE A1254 CYH A1256	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-3.7A) SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) 9HJ  A3006 ( 4.3A) 9HJ  A3006 (-4.6A) SAM  A3001 ( 4.5A) ZN  A3005 ( 2.4A)	0.58A	5jhnA-5vsdA: 40.3	5jhnA-5vsdA: 77.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5JHN_B_SAMB1205_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	11 / 12	MET A1136 GLY A1137 TRP A1138 SER A1172 TYR A1173 ASN A1200 HIS A1201 TYR A1242 PHE A1246 PHE A1254 CYH A1256	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-3.7A) SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) 9HJ  A3006 ( 4.3A) SAM  A3001 ( 4.5A) ZN  A3005 ( 2.4A)	0.49A	5jhnB-5vsdA: 40.0	5jhnB-5vsdA: 77.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5JIN_A_SAMA1205_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	11 / 12	MET A1136 GLY A1137 TRP A1138 SER A1172 TYR A1173 HIS A1201 TYR A1242 PHE A1246 LYS A1250 PHE A1254 CYH A1256	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-3.7A) SAM  A3001 (-4.0A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) 9HJ  A3006 ( 4.3A) 9HJ  A3006 (-4.6A) SAM  A3001 ( 4.5A) ZN  A3005 ( 2.4A)	0.61A	5jinA-5vsdA: 40.4	5jinA-5vsdA: 77.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5JIN_B_SAMB1205_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	11 / 12	MET A1136 TRP A1138 SER A1172 TYR A1173 ASN A1200 HIS A1201 TYR A1242 PHE A1246 LYS A1250 PHE A1254 CYH A1256	SAM  A3001 (-3.4A) None SAM  A3001 (-3.7A) SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) 9HJ  A3006 ( 4.3A) 9HJ  A3006 (-4.6A) SAM  A3001 ( 4.5A) ZN  A3005 ( 2.4A)	0.62A	5jinB-5vsdA: 40.0	5jinB-5vsdA: 77.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5JIY_A_SAMA1205_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	12 / 12	MET A1136 GLY A1137 TRP A1138 SER A1172 TYR A1173 ASN A1200 HIS A1201 TYR A1242 PHE A1246 LYS A1250 PHE A1254 CYH A1256	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-3.7A) SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) 9HJ  A3006 ( 4.3A) 9HJ  A3006 (-4.6A) SAM  A3001 ( 4.5A) ZN  A3005 ( 2.4A)	0.59A	5jiyA-5vsdA: 40.3	5jiyA-5vsdA: 77.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5JIY_B_SAMB1205_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	12 / 12	MET A1136 GLY A1137 TRP A1138 SER A1172 TYR A1173 ASN A1200 HIS A1201 TYR A1242 PHE A1246 LYS A1250 PHE A1254 CYH A1256	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-3.7A) SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) 9HJ  A3006 ( 4.3A) 9HJ  A3006 (-4.6A) SAM  A3001 ( 4.5A) ZN  A3005 ( 2.4A)	0.60A	5jiyB-5vsdA: 39.8	5jiyB-5vsdA: 77.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5JJ0_A_SAMA1205_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	11 / 12	MET A1136 GLY A1137 TRP A1138 SER A1172 TYR A1173 HIS A1201 TYR A1242 PHE A1246 LYS A1250 PHE A1254 CYH A1256	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-3.7A) SAM  A3001 (-4.0A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) 9HJ  A3006 ( 4.3A) 9HJ  A3006 (-4.6A) SAM  A3001 ( 4.5A) ZN  A3005 ( 2.4A)	0.60A	5jj0A-5vsdA: 40.3	5jj0A-5vsdA: 77.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5JJ0_B_SAMB1205_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	11 / 12	MET A1136 GLY A1137 TRP A1138 SER A1172 ASN A1200 HIS A1201 TYR A1242 PHE A1246 LYS A1250 PHE A1254 CYH A1256	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-3.7A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) 9HJ  A3006 ( 4.3A) 9HJ  A3006 (-4.6A) SAM  A3001 ( 4.5A) ZN  A3005 ( 2.4A)	0.61A	5jj0B-5vsdA: 39.9	5jj0B-5vsdA: 77.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5KKL_B_SAMB8009_0 (PUTATIVE UNCHARACTERIZED PROTEIN,HISTONE H3.1 PEPTIDE,ZINC FINGER DOMAIN-CONTAINING PROTEIN)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	5 / 12	GLY A1137 ASN A1200 HIS A1201 TYR A1242 PHE A1246	SAM  A3001 (-3.6A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) 9HJ  A3006 ( 4.3A)	0.66A	5kklB-5vsdA: 5.4	5kklB-5vsdA: 15.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LSU_A_SAMA1304_0 (HISTONE-LYSINE N-METHYLTRANSFERASE NSD2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	6 / 12	GLY A1137 TRP A1138 TYR A1173 HIS A1201 CYH A1256 CYH A1258	SAM  A3001 (-3.6A) None SAM  A3001 (-4.0A) SAM  A3001 (-4.6A) ZN  A3005 ( 2.4A) ZN  A3005 (-2.3A)	0.41A	5lsuA-5vsdA: 20.2	5lsuA-5vsdA: 26.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LSU_B_SAMB1304_0 (HISTONE-LYSINE N-METHYLTRANSFERASE NSD2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	5 / 12	GLY A1137 TRP A1138 TYR A1173 HIS A1201 CYH A1258	SAM  A3001 (-3.6A) None SAM  A3001 (-4.0A) SAM  A3001 (-4.6A) ZN  A3005 (-2.3A)	0.43A	5lsuB-5vsdA: 19.9	5lsuB-5vsdA: 26.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LSU_B_SAMB1304_1 (HISTONE-LYSINE N-METHYLTRANSFERASE NSD2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	3 / 3	ASN A1200 TYR A1242 CYH A1256	SAM  A3001 (-3.4A) SAM  A3001 (-4.8A) ZN  A3005 ( 2.4A)	0.12A	5lsuB-5vsdA: 19.9	5lsuB-5vsdA: 26.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5T0K_A_SAMA1304_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	5 / 12	GLY A1139 TYR A1173 HIS A1201 TYR A1242 PHE A1246	None SAM  A3001 (-4.0A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) 9HJ  A3006 ( 4.3A)	1.06A	5t0kA-5vsdA: 40.0	5t0kA-5vsdA: 77.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5T0K_A_SAMA1304_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	6 / 12	MET A1136 GLY A1137 TRP A1138 HIS A1201 TYR A1242 CYH A1258	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.47A	5t0kA-5vsdA: 40.0	5t0kA-5vsdA: 77.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5T0K_A_SAMA1304_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	11 / 12	MET A1136 GLY A1137 TRP A1138 SER A1172 TYR A1173 ASN A1200 HIS A1201 TYR A1242 PHE A1246 PHE A1254 CYH A1256	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-3.7A) SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) 9HJ  A3006 ( 4.3A) SAM  A3001 ( 4.5A) ZN  A3005 ( 2.4A)	0.49A	5t0kA-5vsdA: 40.0	5t0kA-5vsdA: 77.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5T0K_B_SAMB1304_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	6 / 12	MET A1136 GLY A1137 TRP A1138 HIS A1201 TYR A1242 CYH A1258	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.46A	5t0kB-5vsdA: 37.2	5t0kB-5vsdA: 77.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5T0K_B_SAMB1304_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	10 / 12	MET A1136 GLY A1137 TRP A1138 SER A1172 ASN A1200 HIS A1201 TYR A1242 PHE A1246 PHE A1254 CYH A1256	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-3.7A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) 9HJ  A3006 ( 4.3A) SAM  A3001 ( 4.5A) ZN  A3005 ( 2.4A)	0.48A	5t0kB-5vsdA: 37.2	5t0kB-5vsdA: 77.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5T0K_B_SAMB1304_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	9 / 12	MET A1136 SER A1172 ASN A1200 HIS A1201 TYR A1242 PHE A1246 LYS A1250 PHE A1254 CYH A1256	SAM  A3001 (-3.4A) SAM  A3001 (-3.7A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) 9HJ  A3006 ( 4.3A) 9HJ  A3006 (-4.6A) SAM  A3001 ( 4.5A) ZN  A3005 ( 2.4A)	0.58A	5t0kB-5vsdA: 37.2	5t0kB-5vsdA: 77.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5T0M_A_SAMA1205_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	11 / 12	MET A1136 TRP A1138 SER A1172 TYR A1173 ASN A1200 HIS A1201 TYR A1242 PHE A1246 LYS A1250 PHE A1254 CYH A1256	SAM  A3001 (-3.4A) None SAM  A3001 (-3.7A) SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) 9HJ  A3006 ( 4.3A) 9HJ  A3006 (-4.6A) SAM  A3001 ( 4.5A) ZN  A3005 ( 2.4A)	0.57A	5t0mA-5vsdA: 40.0	5t0mA-5vsdA: 77.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5T0M_B_SAMB1205_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	11 / 12	MET A1136 GLY A1137 TRP A1138 SER A1172 TYR A1173 ASN A1200 HIS A1201 TYR A1242 PHE A1246 PHE A1254 CYH A1256	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-3.7A) SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) 9HJ  A3006 ( 4.3A) SAM  A3001 ( 4.5A) ZN  A3005 ( 2.4A)	0.50A	5t0mB-5vsdA: 40.4	5t0mB-5vsdA: 77.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TEG_B_SAMB401_0 (HISTONE H4 MUTANT PEPTIDE WITH H4K20NORLEUCINE N-LYSINE METHYLTRANSFERASE KMT5A)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	5 / 10	GLY A1137 TYR A1173 ASN A1200 HIS A1201 TYR A1242	SAM  A3001 (-3.6A) SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A)	0.24A	5tegB-5vsdA: 13.8 5tegE-5vsdA: undetectable	5tegB-5vsdA: 23.99 5tegE-5vsdA: 3.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TQR_B_SAMB8009_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EZH2, POLYCOMB PROTEIN SUZ12)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	5 / 10	GLY A1137 TYR A1173 ASN A1200 HIS A1201 TYR A1242	SAM  A3001 (-3.6A) SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A)	0.41A	5tqrB-5vsdA: 3.8	5tqrB-5vsdA: 15.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5TTF_A_SAMA1505_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	6 / 11	MET A1136 GLY A1137 TRP A1138 HIS A1201 TYR A1242 CYH A1258	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.43A	5ttfA-5vsdA: 41.1	5ttfA-5vsdA: 76.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5TTF_A_SAMA1505_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	11 / 11	MET A1136 GLY A1137 TRP A1138 SER A1172 TYR A1173 ASN A1200 HIS A1201 TYR A1242 PHE A1246 PHE A1254 CYH A1256	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-3.7A) SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) 9HJ  A3006 ( 4.3A) SAM  A3001 ( 4.5A) ZN  A3005 ( 2.4A)	0.28A	5ttfA-5vsdA: 41.1	5ttfA-5vsdA: 76.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5TTF_B_SAMB1505_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	6 / 12	MET A1136 GLY A1137 TRP A1138 HIS A1201 TYR A1242 CYH A1258	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.47A	5ttfB-5vsdA: 40.5	5ttfB-5vsdA: 76.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5TTF_B_SAMB1505_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	11 / 12	MET A1136 GLY A1137 TRP A1138 SER A1172 TYR A1173 ASN A1200 HIS A1201 TYR A1242 PHE A1246 PHE A1254 CYH A1256	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-3.7A) SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) 9HJ  A3006 ( 4.3A) SAM  A3001 ( 4.5A) ZN  A3005 ( 2.4A)	0.27A	5ttfB-5vsdA: 40.5	5ttfB-5vsdA: 76.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5TTF_C_SAMC1505_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	11 / 12	MET A1136 GLY A1137 TRP A1138 SER A1172 ASN A1200 HIS A1201 TYR A1242 PHE A1246 TRP A1247 PHE A1254 CYH A1256	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-3.7A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) 9HJ  A3006 ( 4.3A) None SAM  A3001 ( 4.5A) ZN  A3005 ( 2.4A)	0.33A	5ttfC-5vsdA: 40.1	5ttfC-5vsdA: 76.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5TTF_D_SAMD1505_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	11 / 11	MET A1136 GLY A1137 TRP A1138 SER A1172 TYR A1173 ASN A1200 HIS A1201 TYR A1242 PHE A1246 PHE A1254 CYH A1256	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-3.7A) SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) 9HJ  A3006 ( 4.3A) SAM  A3001 ( 4.5A) ZN  A3005 ( 2.4A)	0.22A	5ttfD-5vsdA: 41.5	5ttfD-5vsdA: 76.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5TTF_D_SAMD1505_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	7 / 11	MET A1136 GLY A1137 TRP A1138 TYR A1173 HIS A1201 TYR A1242 CYH A1258	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-4.0A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.49A	5ttfD-5vsdA: 41.5	5ttfD-5vsdA: 76.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5TTG_A_SAMA1301_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	6 / 12	MET A1136 GLY A1137 TRP A1138 HIS A1201 TYR A1242 CYH A1258	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.41A	5ttgA-5vsdA: 43.1	5ttgA-5vsdA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5TTG_A_SAMA1301_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	5 / 12	MET A1136 GLY A1137 TRP A1138 HIS A1202 CYH A1258	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None None ZN  A3005 (-2.3A)	1.44A	5ttgA-5vsdA: 43.1	5ttgA-5vsdA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5TTG_A_SAMA1301_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	11 / 12	MET A1136 GLY A1137 TRP A1138 SER A1172 TYR A1173 ASN A1200 HIS A1201 TYR A1242 PHE A1246 PHE A1254 CYH A1256	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-3.7A) SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) 9HJ  A3006 ( 4.3A) SAM  A3001 ( 4.5A) ZN  A3005 ( 2.4A)	0.10A	5ttgA-5vsdA: 43.1	5ttgA-5vsdA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5TTG_A_SAMA1301_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	10 / 12	MET A1136 SER A1172 TYR A1173 ASN A1200 HIS A1201 TYR A1242 PHE A1246 PHE A1254 CYH A1256 ARG A1257	SAM  A3001 (-3.4A) SAM  A3001 (-3.7A) SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) 9HJ  A3006 ( 4.3A) SAM  A3001 ( 4.5A) ZN  A3005 ( 2.4A) SAM  A3001 (-4.3A)	0.45A	5ttgA-5vsdA: 43.1	5ttgA-5vsdA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5TTG_B_SAMB1301_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	6 / 11	MET A1136 GLY A1137 TRP A1138 HIS A1201 TYR A1242 CYH A1258	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.42A	5ttgB-5vsdA: 43.6	5ttgB-5vsdA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5TTG_B_SAMB1301_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	5 / 11	MET A1136 GLY A1137 TRP A1138 HIS A1202 CYH A1258	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None None ZN  A3005 (-2.3A)	1.43A	5ttgB-5vsdA: 43.6	5ttgB-5vsdA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5TTG_B_SAMB1301_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	11 / 11	MET A1136 GLY A1137 TRP A1138 SER A1172 TYR A1173 ASN A1200 HIS A1201 TYR A1242 PHE A1246 PHE A1254 CYH A1256	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-3.7A) SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) 9HJ  A3006 ( 4.3A) SAM  A3001 ( 4.5A) ZN  A3005 ( 2.4A)	0.11A	5ttgB-5vsdA: 43.6	5ttgB-5vsdA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5TUY_A_SAMA1505_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	11 / 12	MET A1136 GLY A1137 TRP A1138 SER A1172 TYR A1173 ASN A1200 HIS A1201 TYR A1242 PHE A1246 PHE A1254 CYH A1256	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-3.7A) SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) 9HJ  A3006 ( 4.3A) SAM  A3001 ( 4.5A) ZN  A3005 ( 2.4A)	0.34A	5tuyA-5vsdA: 40.0	5tuyA-5vsdA: 79.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5TUY_A_SAMA1505_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	7 / 12	MET A1136 GLY A1137 TRP A1138 TYR A1173 HIS A1201 TYR A1242 CYH A1258	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-4.0A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.47A	5tuyA-5vsdA: 40.0	5tuyA-5vsdA: 79.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5TUY_B_SAMB1505_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	11 / 12	MET A1136 GLY A1137 TRP A1138 SER A1172 TYR A1173 ASN A1200 HIS A1201 TYR A1242 PHE A1246 PHE A1254 CYH A1256	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-3.7A) SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) 9HJ  A3006 ( 4.3A) SAM  A3001 ( 4.5A) ZN  A3005 ( 2.4A)	0.38A	5tuyB-5vsdA: 39.6	5tuyB-5vsdA: 79.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5TUY_B_SAMB1505_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	7 / 12	MET A1136 GLY A1137 TRP A1138 TYR A1173 HIS A1201 TYR A1242 CYH A1258	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-4.0A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.48A	5tuyB-5vsdA: 39.6	5tuyB-5vsdA: 79.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5TUZ_A_SAMA3001_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	12 / 12	MET A1136 GLY A1137 TRP A1138 SER A1172 ASN A1200 HIS A1201 TYR A1242 PHE A1246 PHE A1254 CYH A1256 ARG A1257 CYH A1258	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-3.7A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) 9HJ  A3006 ( 4.3A) SAM  A3001 ( 4.5A) ZN  A3005 ( 2.4A) SAM  A3001 (-4.3A) ZN  A3005 (-2.3A)	0.48A	5tuzA-5vsdA: 43.6	5tuzA-5vsdA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5TUZ_B_SAMB3001_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	12 / 12	MET A1136 GLY A1137 TRP A1138 SER A1172 TYR A1173 ASN A1200 HIS A1201 TYR A1242 PHE A1246 PHE A1254 CYH A1256 ARG A1257	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-3.7A) SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) 9HJ  A3006 ( 4.3A) SAM  A3001 ( 4.5A) ZN  A3005 ( 2.4A) SAM  A3001 (-4.3A)	0.43A	5tuzB-5vsdA: 43.3	5tuzB-5vsdA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5TUZ_B_SAMB3001_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	7 / 12	MET A1136 GLY A1137 TRP A1138 TYR A1173 HIS A1201 TYR A1242 CYH A1258	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-4.0A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.45A	5tuzB-5vsdA: 43.3	5tuzB-5vsdA: 100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UPD_A_SAMA1301_0 (HISTONE-LYSINE N-METHYLTRANSFERASE NSD3)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	5 / 11	GLY A1137 TRP A1138 HIS A1201 TYR A1242 CYH A1256	SAM  A3001 (-3.6A) None SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 ( 2.4A)	1.46A	5updA-5vsdA: 19.8	5updA-5vsdA: 27.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UPD_A_SAMA1301_0 (HISTONE-LYSINE N-METHYLTRANSFERASE NSD3)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	8 / 11	GLY A1137 TRP A1138 TYR A1173 ASN A1200 HIS A1201 TYR A1242 CYH A1256 CYH A1258	SAM  A3001 (-3.6A) None SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 ( 2.4A) ZN  A3005 (-2.3A)	0.51A	5updA-5vsdA: 19.8	5updA-5vsdA: 27.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UPD_A_SAMA1301_0 (HISTONE-LYSINE N-METHYLTRANSFERASE NSD3)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	5 / 11	GLY A1139 TYR A1173 HIS A1201 TYR A1242 CYH A1258	None SAM  A3001 (-4.0A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.47A	5updA-5vsdA: 19.8	5updA-5vsdA: 27.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UUN_B_ACTB309_0 (GLUTATHIONE S-TRANSFERASE-LIKE PROTEIN)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	3 / 3	TYR A1038 ALA A1015 TYR A1040	None	0.84A	5uunB-5vsdA: undetectable	5uunB-5vsdA: 22.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V21_A_SAMA1804_0 (HISTONE-LYSINE N-METHYLTRANSFERASE SETD2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	7 / 12	GLY A1137 TRP A1138 TYR A1173 ASN A1200 HIS A1201 TYR A1242 CYH A1256	SAM  A3001 (-3.6A) None SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 ( 2.4A)	0.54A	5v21A-5vsdA: 18.6	5v21A-5vsdA: 28.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V21_A_SAMA1804_0 (HISTONE-LYSINE N-METHYLTRANSFERASE SETD2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	6 / 12	GLY A1137 TRP A1138 TYR A1173 HIS A1201 TYR A1242 CYH A1258	SAM  A3001 (-3.6A) None SAM  A3001 (-4.0A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.39A	5v21A-5vsdA: 18.6	5v21A-5vsdA: 28.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5V9I_A_SAMA1505_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	6 / 12	MET A1136 GLY A1137 TRP A1138 HIS A1201 TYR A1242 CYH A1258	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.43A	5v9iA-5vsdA: 40.8	5v9iA-5vsdA: 76.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5V9I_A_SAMA1505_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	11 / 12	MET A1136 GLY A1137 TRP A1138 SER A1172 TYR A1173 ASN A1200 HIS A1201 TYR A1242 PHE A1246 PHE A1254 CYH A1256	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-3.7A) SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) 9HJ  A3006 ( 4.3A) SAM  A3001 ( 4.5A) ZN  A3005 ( 2.4A)	0.23A	5v9iA-5vsdA: 40.8	5v9iA-5vsdA: 76.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5V9I_B_SAMB1505_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	6 / 11	MET A1136 GLY A1137 TRP A1138 HIS A1201 TYR A1242 CYH A1258	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.46A	5v9iB-5vsdA: 40.8	5v9iB-5vsdA: 76.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5V9I_B_SAMB1505_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	11 / 11	MET A1136 GLY A1137 TRP A1138 SER A1172 TYR A1173 ASN A1200 HIS A1201 TYR A1242 PHE A1246 PHE A1254 CYH A1256	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-3.7A) SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) 9HJ  A3006 ( 4.3A) SAM  A3001 ( 4.5A) ZN  A3005 ( 2.4A)	0.25A	5v9iB-5vsdA: 40.8	5v9iB-5vsdA: 76.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5V9I_C_SAMC1505_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	11 / 11	MET A1136 GLY A1137 TRP A1138 SER A1172 TYR A1173 ASN A1200 HIS A1201 TYR A1242 PHE A1246 PHE A1254 CYH A1256	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-3.7A) SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) 9HJ  A3006 ( 4.3A) SAM  A3001 ( 4.5A) ZN  A3005 ( 2.4A)	0.22A	5v9iC-5vsdA: 41.1	5v9iC-5vsdA: 76.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5V9I_C_SAMC1505_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	7 / 11	MET A1136 GLY A1137 TRP A1138 TYR A1173 HIS A1201 TYR A1242 CYH A1258	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-4.0A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.48A	5v9iC-5vsdA: 41.1	5v9iC-5vsdA: 76.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5V9I_D_SAMD1505_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	11 / 12	MET A1136 GLY A1137 TRP A1138 SER A1172 TYR A1173 HIS A1201 TYR A1242 PHE A1246 TRP A1247 PHE A1254 CYH A1256	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-3.7A) SAM  A3001 (-4.0A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) 9HJ  A3006 ( 4.3A) None SAM  A3001 ( 4.5A) ZN  A3005 ( 2.4A)	0.31A	5v9iD-5vsdA: 40.7	5v9iD-5vsdA: 76.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5V9J_A_SAMA1301_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	6 / 12	MET A1136 GLY A1137 TRP A1138 HIS A1201 TYR A1242 CYH A1258	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.40A	5v9jA-5vsdA: 43.0	5v9jA-5vsdA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5V9J_A_SAMA1301_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	5 / 12	MET A1136 GLY A1137 TRP A1138 HIS A1202 CYH A1258	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None None ZN  A3005 (-2.3A)	1.46A	5v9jA-5vsdA: 43.0	5v9jA-5vsdA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5V9J_A_SAMA1301_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	12 / 12	MET A1136 GLY A1137 TRP A1138 SER A1172 TYR A1173 ASN A1200 HIS A1201 TYR A1242 PHE A1246 PHE A1254 CYH A1256 ARG A1257	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-3.7A) SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) 9HJ  A3006 ( 4.3A) SAM  A3001 ( 4.5A) ZN  A3005 ( 2.4A) SAM  A3001 (-4.3A)	0.39A	5v9jA-5vsdA: 43.0	5v9jA-5vsdA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5V9J_B_SAMB1301_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	6 / 12	MET A1136 GLY A1137 TRP A1138 HIS A1201 TYR A1242 CYH A1258	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.42A	5v9jB-5vsdA: 43.4	5v9jB-5vsdA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5V9J_B_SAMB1301_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	5 / 12	MET A1136 GLY A1137 TRP A1138 HIS A1202 CYH A1258	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None None ZN  A3005 (-2.3A)	1.43A	5v9jB-5vsdA: 43.4	5v9jB-5vsdA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5V9J_B_SAMB1301_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	11 / 12	MET A1136 GLY A1137 TRP A1138 SER A1172 TYR A1173 ASN A1200 HIS A1201 TYR A1242 PHE A1246 PHE A1254 CYH A1256	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-3.7A) SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) 9HJ  A3006 ( 4.3A) SAM  A3001 ( 4.5A) ZN  A3005 ( 2.4A)	0.11A	5v9jB-5vsdA: 43.4	5v9jB-5vsdA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5V9J_B_SAMB1301_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	8 / 12	SER A1172 TYR A1173 HIS A1201 TYR A1242 PHE A1246 PHE A1254 CYH A1256 ARG A1257	SAM  A3001 (-3.7A) SAM  A3001 (-4.0A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) 9HJ  A3006 ( 4.3A) SAM  A3001 ( 4.5A) ZN  A3005 ( 2.4A) SAM  A3001 (-4.3A)	0.78A	5v9jB-5vsdA: 43.4	5v9jB-5vsdA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5VSC_A_SAMA1505_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	6 / 12	MET A1136 GLY A1137 TRP A1138 HIS A1201 TYR A1242 CYH A1258	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.45A	5vscA-5vsdA: 40.7	5vscA-5vsdA: 77.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5VSC_A_SAMA1505_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	11 / 12	MET A1136 GLY A1137 TRP A1138 SER A1172 TYR A1173 ASN A1200 HIS A1201 TYR A1242 PHE A1246 PHE A1254 CYH A1256	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-3.7A) SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) 9HJ  A3006 ( 4.3A) SAM  A3001 ( 4.5A) ZN  A3005 ( 2.4A)	0.38A	5vscA-5vsdA: 40.7	5vscA-5vsdA: 77.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5VSC_B_SAMB1505_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	7 / 12	MET A1136 GLY A1137 TRP A1138 ASN A1200 HIS A1201 TYR A1242 CYH A1258	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.33A	5vscB-5vsdA: 40.9	5vscB-5vsdA: 77.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5VSC_B_SAMB1505_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	11 / 12	MET A1136 GLY A1137 TRP A1138 SER A1172 TYR A1173 ASN A1200 HIS A1201 TYR A1242 PHE A1246 PHE A1254 CYH A1256	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-3.7A) SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) 9HJ  A3006 ( 4.3A) SAM  A3001 ( 4.5A) ZN  A3005 ( 2.4A)	0.34A	5vscB-5vsdA: 40.9	5vscB-5vsdA: 77.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5VSD_A_SAMA3001_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	6 / 12	MET A1136 GLY A1137 TRP A1138 HIS A1201 TYR A1242 CYH A1258	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.40A	5vsdA-5vsdA: 45.2	5vsdA-5vsdA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5VSD_A_SAMA3001_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	5 / 12	MET A1136 GLY A1137 TRP A1138 HIS A1202 CYH A1258	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None None ZN  A3005 (-2.3A)	1.46A	5vsdA-5vsdA: 45.2	5vsdA-5vsdA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5VSD_A_SAMA3001_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	12 / 12	MET A1136 GLY A1137 TRP A1138 SER A1172 ASN A1200 HIS A1201 TYR A1242 PHE A1246 TRP A1247 PHE A1254 CYH A1256 ARG A1257	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-3.7A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) 9HJ  A3006 ( 4.3A) None SAM  A3001 ( 4.5A) ZN  A3005 ( 2.4A) SAM  A3001 (-4.3A)	0.01A	5vsdA-5vsdA: 45.2	5vsdA-5vsdA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5VSD_B_SAMB3001_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	6 / 12	MET A1136 GLY A1137 TRP A1138 HIS A1201 TYR A1242 CYH A1258	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.42A	5vsdB-5vsdA: 43.5	5vsdB-5vsdA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5VSD_B_SAMB3001_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	5 / 12	MET A1136 GLY A1137 TRP A1138 HIS A1202 CYH A1258	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None None ZN  A3005 (-2.3A)	1.46A	5vsdB-5vsdA: 43.5	5vsdB-5vsdA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5VSD_B_SAMB3001_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	12 / 12	MET A1136 GLY A1137 TRP A1138 SER A1172 TYR A1173 ASN A1200 HIS A1201 TYR A1242 PHE A1246 PHE A1254 CYH A1256 ARG A1257	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-3.7A) SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) 9HJ  A3006 ( 4.3A) SAM  A3001 ( 4.5A) ZN  A3005 ( 2.4A) SAM  A3001 (-4.3A)	0.17A	5vsdB-5vsdA: 43.5	5vsdB-5vsdA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5VSE_A_SAMA1505_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	6 / 12	MET A1136 GLY A1137 TRP A1138 HIS A1201 TYR A1242 CYH A1258	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.47A	5vseA-5vsdA: 40.4	5vseA-5vsdA: 77.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5VSE_A_SAMA1505_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	11 / 12	MET A1136 GLY A1137 TRP A1138 SER A1172 TYR A1173 ASN A1200 HIS A1201 TYR A1242 PHE A1246 PHE A1254 CYH A1256	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-3.7A) SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) 9HJ  A3006 ( 4.3A) SAM  A3001 ( 4.5A) ZN  A3005 ( 2.4A)	0.37A	5vseA-5vsdA: 40.4	5vseA-5vsdA: 77.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5VSE_B_SAMB1505_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	7 / 12	MET A1136 GLY A1137 TRP A1138 ASN A1200 HIS A1201 TYR A1242 CYH A1258	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.35A	5vseB-5vsdA: 40.8	5vseB-5vsdA: 77.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5VSE_B_SAMB1505_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT2)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	11 / 12	MET A1136 GLY A1137 TRP A1138 SER A1172 TYR A1173 ASN A1200 HIS A1201 TYR A1242 PHE A1246 PHE A1254 CYH A1256	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-3.7A) SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) 9HJ  A3006 ( 4.3A) SAM  A3001 ( 4.5A) ZN  A3005 ( 2.4A)	0.36A	5vseB-5vsdA: 40.8	5vseB-5vsdA: 77.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5VSF_A_SAMA3001_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	6 / 12	MET A1136 GLY A1137 TRP A1138 HIS A1201 TYR A1242 CYH A1258	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.41A	5vsfA-5vsdA: 43.6	5vsfA-5vsdA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5VSF_A_SAMA3001_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	5 / 12	MET A1136 GLY A1137 TRP A1138 HIS A1202 CYH A1258	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None None ZN  A3005 (-2.3A)	1.43A	5vsfA-5vsdA: 43.6	5vsfA-5vsdA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5VSF_A_SAMA3001_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	12 / 12	MET A1136 GLY A1137 TRP A1138 SER A1172 ASN A1200 HIS A1201 TYR A1242 PHE A1246 TRP A1247 PHE A1254 CYH A1256 ARG A1257	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-3.7A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) 9HJ  A3006 ( 4.3A) None SAM  A3001 ( 4.5A) ZN  A3005 ( 2.4A) SAM  A3001 (-4.3A)	0.11A	5vsfA-5vsdA: 43.6	5vsfA-5vsdA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5VSF_B_SAMB3001_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	6 / 12	MET A1136 GLY A1137 TRP A1138 HIS A1201 TYR A1242 CYH A1258	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.41A	5vsfB-5vsdA: 43.3	5vsfB-5vsdA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5VSF_B_SAMB3001_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	5 / 12	MET A1136 GLY A1137 TRP A1138 HIS A1202 CYH A1258	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None None ZN  A3005 (-2.3A)	1.47A	5vsfB-5vsdA: 43.3	5vsfB-5vsdA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5VSF_B_SAMB3001_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	12 / 12	MET A1136 GLY A1137 TRP A1138 SER A1172 TYR A1173 ASN A1200 HIS A1201 TYR A1242 PHE A1246 PHE A1254 CYH A1256 ARG A1257	SAM  A3001 (-3.4A) SAM  A3001 (-3.6A) None SAM  A3001 (-3.7A) SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) 9HJ  A3006 ( 4.3A) SAM  A3001 ( 4.5A) ZN  A3005 ( 2.4A) SAM  A3001 (-4.3A)	0.13A	5vsfB-5vsdA: 43.3	5vsfB-5vsdA: 100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A5K_A_SAMA805_0 (HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC SUVH6)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	7 / 12	GLY A1137 TRP A1138 ASN A1200 HIS A1201 TYR A1242 CYH A1256 CYH A1258	SAM  A3001 (-3.6A) None SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 ( 2.4A) ZN  A3005 (-2.3A)	0.39A	6a5kA-5vsdA: 28.4	6a5kA-5vsdA: 22.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A5K_A_SAMA805_0 (HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC SUVH6)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	5 / 12	GLY A1137 TRP A1138 HIS A1201 TYR A1242 CYH A1258	SAM  A3001 (-3.6A) None SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.35A	6a5kA-5vsdA: 28.4	6a5kA-5vsdA: 22.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A5K_A_SAMA805_0 (HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC SUVH6)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	5 / 12	GLY A1139 HIS A1201 TYR A1242 CYH A1256 CYH A1258	None SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 ( 2.4A) ZN  A3005 (-2.3A)	1.17A	6a5kA-5vsdA: 28.4	6a5kA-5vsdA: 22.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A5M_A_SAMA805_0 (HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC SUVH6)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	8 / 12	GLY A1137 TRP A1138 TYR A1173 ASN A1200 HIS A1201 TYR A1242 CYH A1256 CYH A1258	SAM  A3001 (-3.6A) None SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 ( 2.4A) ZN  A3005 (-2.3A)	0.54A	6a5mA-5vsdA: 28.6	6a5mA-5vsdA: 22.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A5M_A_SAMA805_0 (HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC SUVH6)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	6 / 12	GLY A1137 TRP A1138 TYR A1173 HIS A1201 TYR A1242 CYH A1258	SAM  A3001 (-3.6A) None SAM  A3001 (-4.0A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.41A	6a5mA-5vsdA: 28.6	6a5mA-5vsdA: 22.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A5M_A_SAMA805_0 (HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC SUVH6)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	5 / 12	GLY A1139 TYR A1173 HIS A1201 TYR A1242 CYH A1258	None SAM  A3001 (-4.0A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.14A	6a5mA-5vsdA: 28.6	6a5mA-5vsdA: 22.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6AGO_A_SAMA2301_0 (HISTONE-LYSINE N-METHYLTRANSFERASE ASH1L)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	5 / 11	GLY A1137 TRP A1138 ASN A1200 HIS A1201 CYH A1256	SAM  A3001 (-3.6A) None SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) ZN  A3005 ( 2.4A)	1.34A	6agoA-5vsdA: 18.2	6agoA-5vsdA: 27.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6AGO_A_SAMA2301_0 (HISTONE-LYSINE N-METHYLTRANSFERASE ASH1L)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	7 / 11	GLY A1137 TRP A1138 ASN A1200 HIS A1201 TYR A1242 CYH A1256 CYH A1258	SAM  A3001 (-3.6A) None SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 ( 2.4A) ZN  A3005 (-2.3A)	0.85A	6agoA-5vsdA: 18.2	6agoA-5vsdA: 27.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6AGO_A_SAMA2301_0 (HISTONE-LYSINE N-METHYLTRANSFERASE ASH1L)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	7 / 11	GLY A1137 TYR A1173 ASN A1200 HIS A1201 TYR A1242 CYH A1256 CYH A1258	SAM  A3001 (-3.6A) SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 ( 2.4A) ZN  A3005 (-2.3A)	0.94A	6agoA-5vsdA: 18.2	6agoA-5vsdA: 27.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6BP4_A_SAMA505_0 (HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	6 / 12	GLY A1137 TRP A1138 ARG A1197 HIS A1201 TYR A1242 CYH A1258	SAM  A3001 (-3.6A) None None SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	0.75A	6bp4A-5vsdA: 26.8	6bp4A-5vsdA: 35.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6BP4_B_SAMB505_0 (HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	7 / 12	GLY A1137 TRP A1138 TYR A1173 HIS A1201 TYR A1242 CYH A1256 CYH A1258	SAM  A3001 (-3.6A) None SAM  A3001 (-4.0A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 ( 2.4A) ZN  A3005 (-2.3A)	0.50A	6bp4B-5vsdA: 26.8	6bp4B-5vsdA: 35.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6BP4_B_SAMB505_0 (HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	6 / 12	GLY A1137 TRP A1138 TYR A1173 HIS A1201 TYR A1242 CYH A1258	SAM  A3001 (-3.6A) None SAM  A3001 (-4.0A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.31A	6bp4B-5vsdA: 26.8	6bp4B-5vsdA: 35.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6BP4_B_SAMB505_0 (HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	5 / 12	GLY A1139 TYR A1173 HIS A1201 TYR A1242 CYH A1258	None SAM  A3001 (-4.0A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	0.97A	6bp4B-5vsdA: 26.8	6bp4B-5vsdA: 35.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6BP4_B_SAMB505_0 (HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	5 / 12	GLY A1139 TYR A1173 HIS A1201 TYR A1242 CYH A1258	None SAM  A3001 (-4.0A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.45A	6bp4B-5vsdA: 26.8	6bp4B-5vsdA: 35.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6CEN_A_SAMA1301_0 (HISTONE-LYSINE N-METHYLTRANSFERASE NSD3)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	5 / 11	GLY A1137 TRP A1138 HIS A1201 TYR A1242 CYH A1256	SAM  A3001 (-3.6A) None SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 ( 2.4A)	1.50A	6cenA-5vsdA: 20.1	6cenA-5vsdA: 27.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6CEN_A_SAMA1301_0 (HISTONE-LYSINE N-METHYLTRANSFERASE NSD3)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	8 / 11	GLY A1137 TRP A1138 TYR A1173 ASN A1200 HIS A1201 TYR A1242 CYH A1256 CYH A1258	SAM  A3001 (-3.6A) None SAM  A3001 (-4.0A) SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 ( 2.4A) ZN  A3005 (-2.3A)	0.51A	6cenA-5vsdA: 20.1	6cenA-5vsdA: 27.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6CEN_A_SAMA1301_0 (HISTONE-LYSINE N-METHYLTRANSFERASE NSD3)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	5 / 11	GLY A1139 TYR A1173 HIS A1201 TYR A1242 CYH A1258	None SAM  A3001 (-4.0A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.46A	6cenA-5vsdA: 20.1	6cenA-5vsdA: 27.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6CHG_C_SAMC1101_0 (HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-4 SPECIFIC)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	6 / 12	TRP A1138 SER A1172 TYR A1173 PHE A1198 ASN A1200 HIS A1201	None SAM  A3001 (-3.7A) SAM  A3001 (-4.0A) None SAM  A3001 (-3.4A) SAM  A3001 (-4.6A)	1.15A	6chgC-5vsdA: 9.1	6chgC-5vsdA: 29.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6INE_A_SAMA2304_0 (HISTONE-LYSINE N-METHYLTRANSFERASE ASH1L)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	7 / 12	GLY A1137 TRP A1138 ASN A1200 HIS A1201 TYR A1242 CYH A1256 CYH A1258	SAM  A3001 (-3.6A) None SAM  A3001 (-3.4A) SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 ( 2.4A) ZN  A3005 (-2.3A)	0.39A	6ineA-5vsdA: 17.9	6ineA-5vsdA: 26.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6INE_A_SAMA2304_0 (HISTONE-LYSINE N-METHYLTRANSFERASE ASH1L)	5vsd	HISTONE-LYSINE N-METHYLTRANSFERASE EHMT1 (Homo sapiens)	5 / 12	GLY A1137 TRP A1138 HIS A1201 TYR A1242 CYH A1258	SAM  A3001 (-3.6A) None SAM  A3001 (-4.6A) SAM  A3001 (-4.8A) ZN  A3005 (-2.3A)	1.31A	6ineA-5vsdA: 17.9	6ineA-5vsdA: 26.35